Skip to main content
SpringerLink
Log in

Synthesis and biological activity of DL-3-[4-[4-(2-pyridyl)-1-piperazinyl]butyl]-1,8,8-trimethyl-3-azabicyclo[3,2,1]octan-2,4-dione dihydrochloride

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. G. A. Klygul' and V. A. Krivolapov, Farmakol. Toksikol.,29, No. 2, 241–244 (1966).

    Google Scholar 

  2. S. V. Naletov, T. I. Klimchuk, and I. V. Komissarov, Éksp. Klin. Farmakol., No. 4, 60–62 (1993).

    Google Scholar 

  3. I. V. Komissarov, V. I. Dulenko, V. N. Voshchula, et al., “DL-3-[4-[4-(2-pyridyl)-1-piperazinyl]butyl]1,8,8-trimethyl-3-azabicyclo[3,2,1]octan-2,4-dione, a compound with anxiolytic, neuroleptic, and antiemetic activities,” Patent 1825501, MKI A61K 31/435 USSR. Applied for 29.10.90. Otkrytiya, No. 24 (1993).

  4. J. Boissier, P. Simon, and J.-M. Lwoff, Therapie,19, No. 3, 571–583 (1964).

    Google Scholar 

  5. N. M. Dunham and T. S. Mija, J. Am. Pharm. Ass. Sci. Ed.,46, No. 3, 208–209 (1957).

    Google Scholar 

  6. R. Goa and A. Ward, Drugs, 32, No. 2, 114–129 (1986).

    Google Scholar 

  7. P. L. Howard, N. W. Steward, E. A. Conroy, and J. J. Denton, J. Org. Chem.,18, No. 11, 1484–1488 (1953).

    Google Scholar 

  8. P. Presiosi, M. Vacca, G. Ripanti, and P. Navarra, Arch. Int. Pharmacodyn.,298, 301–302 (1989).

    Google Scholar 

  9. P. Protais, J. Costentin, and J. C. Schwartz, Psychopharmacol.,50, No. 1, 1–6 (1976).

    Google Scholar 

  10. Europe Pat. 0,268,369, Int. Cl.C 07 D 403/14, A61K 31/495. Bridged bicyclic imides as anxiolytics and antidepressants/Bright G. M. Publ. 25.05.88. Bull. 88/21.

  11. Y. H. Wu and J. W. Rayburn, “N-(heteroarylcyclic)-piperizinylalkylazaspiroalkanediones,” Patent 3,717,634 (USA), Int. Cl. CO7D 5/42, published 20.02.73.

  12. I. V. Komissarov, V. I. Dulenko, V. N. Voshchula, et al., “DL-3-[4-[4-(2-pyridyl)-1-piperazinyl]butyl] 1,8,8-trimethyl-3-azabicyclo[3,2,1]octan-2,4-dione, having psychotropic and antiemetic effect,” Patent 5,187,277 (USA), Int. Cl. CO7D 401/14, published 16.02.93.

Download references

Author information

Authors and Affiliations

  1. M. Gor'kii Donetsk Medical Institute, USSR

    I. V. Komissarov, V. I. Dulenko, V. N. Voshchula, N. A. Kharin, S. V. Naletov & A. B. Mamonov

Authors
  1. I. V. Komissarov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. I. Dulenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. N. Voshchula
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. A. Kharin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. V. Naletov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. B. Mamonov
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated from Khimiko-farmatsevticheskii Zhurnal, No. 9, pp. 27–29, September, 1994.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Komissarov, I.V., Dulenko, V.I., Voshchula, V.N. et al. Synthesis and biological activity of DL-3-[4-[4-(2-pyridyl)-1-piperazinyl]butyl]-1,8,8-trimethyl-3-azabicyclo[3,2,1]octan-2,4-dione dihydrochloride. Pharm Chem J 28, 638–640 (1994). https://doi.org/10.1007/BF02219202

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02219202

Keywords

Search

Navigation